Headlines

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push – WSJ

gsk to buy nuvalent for $10.6 billion in oncology push


  1. GSK to Buy Nuvalent for $10.6 Billion in Oncology Push  WSJ
  2. Nuvalent shares surge 39% after UK’s GSK agrees to buy the cancer drugmaker for $10.6 billion  CNBC
  3. GSK enters agreement to acquire Nuvalent, Inc.  GSK
  4. GSK to buy US cancer biotech Nuvalent for $10.6bn  Financial Times
  5. GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover  Reuters



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *